HTG Molecular Diagnostics, Inc. Costs and Expenses
HTG Molecular Diagnostics, Inc. reported Costs and Expenses of $6.05 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Expense Statement › Operating Expenses
us-gaap:CostsAndExpenses · last filed 2023-05-11
- HTG Molecular Diagnostics, Inc. costs and expenses for the quarter ending 2023-03-31 was $6.05M, a 18.73% decline year-over-year.
- HTG Molecular Diagnostics, Inc. costs and expenses for the quarter ending 2022-12-31 was $6.99M, a 10.46% decline year-over-year.
- HTG Molecular Diagnostics, Inc. costs and expenses for the quarter ending 2022-09-30 was $5.60M, a 17.06% decline year-over-year.
- HTG Molecular Diagnostics, Inc. costs and expenses for the quarter ending 2022-06-30 was $7.17M, a 16.44% increase year-over-year.
- HTG Molecular Diagnostics, Inc. costs and expenses for fiscal 2022 was $27.20M, a 1.74% increase from fiscal 2021.
- HTG Molecular Diagnostics, Inc. costs and expenses for fiscal 2021 was $26.73M, a 4.99% decline from fiscal 2020.
- HTG Molecular Diagnostics, Inc. costs and expenses for fiscal 2020 was $28.13M, a 26.28% decline from fiscal 2019.
- HTG Molecular Diagnostics, Inc. costs and expenses for fiscal 2019 was $38.16M, a 1.33% increase from fiscal 2018.
| Period end | Costs and Expenses 3 month | Costs and Expenses 6 month | Costs and Expenses 9 month | Costs and Expenses 12 month |
|---|---|---|---|---|
| 2023-03-31 | $6.05M 10-Q · filed 2023-05-11 | $13.04M derived: sum of 2 quarters · filed 2023-05-11 | $18.63M derived: sum of 3 quarters · filed 2023-05-11 | $25.80M derived: sum of 4 quarters · filed 2023-05-11 |
| 2022-12-31 | $6.99M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $12.59M derived: sum of 2 quarters · filed 2023-03-30 | $19.76M derived: sum of 3 quarters · filed 2023-03-30 | $27.20M 10-K · filed 2023-03-30 |
| 2022-09-30 | $5.60M 10-Q · filed 2022-11-10 | $12.77M derived: sum of 2 quarters · filed 2022-11-10 | $20.21M 10-Q · filed 2022-11-10 | $28.01M derived: sum of 4 quarters · filed 2023-05-11 |
| 2022-06-30 | $7.17M 10-Q · filed 2022-08-12 | $14.61M 10-Q · filed 2022-08-12 | $22.41M derived: sum of 3 quarters · filed 2023-05-11 | $29.16M derived: sum of 4 quarters · filed 2023-05-11 |
| 2022-03-31 | $7.44M 10-Q · filed 2023-05-11 | $15.25M derived: sum of 2 quarters · filed 2023-05-11 | $22.00M derived: sum of 3 quarters · filed 2023-05-11 | $28.15M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $7.81M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $14.56M derived: sum of 2 quarters · filed 2023-03-30 | $20.71M derived: sum of 3 quarters · filed 2023-03-30 | $26.73M 10-K · filed 2023-03-30 |
| 2021-09-30 | $6.75M 10-Q · filed 2022-11-10 | $12.91M derived: sum of 2 quarters · filed 2022-11-10 | $18.92M 10-Q · filed 2022-11-10 | $25.53M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $6.16M 10-Q · filed 2022-08-12 | $12.17M 10-Q · filed 2022-08-12 | $18.78M derived: sum of 3 quarters · filed 2022-08-12 | $25.73M derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $6.02M 10-Q · filed 2022-05-12 | $12.62M derived: sum of 2 quarters · filed 2022-05-12 | $19.57M derived: sum of 3 quarters · filed 2022-05-12 | $26.53M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $6.61M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $13.55M derived: sum of 2 quarters · filed 2022-03-29 | $20.52M derived: sum of 3 quarters · filed 2022-03-29 | $28.13M 10-K · filed 2022-03-29 |
| 2020-09-30 | $6.95M 10-Q · filed 2021-11-10 | $13.91M derived: sum of 2 quarters · filed 2021-11-10 | $21.53M 10-Q · filed 2021-11-10 | $30.64M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $6.96M 10-Q · filed 2021-08-12 | $14.58M 10-Q · filed 2021-08-12 | $23.69M derived: sum of 3 quarters · filed 2021-08-12 | $33.72M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $7.62M 10-Q · filed 2021-05-13 | $16.73M derived: sum of 2 quarters · filed 2021-05-13 | $26.76M derived: sum of 3 quarters · filed 2021-05-13 | $37.26M derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $9.11M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $19.14M derived: sum of 2 quarters · filed 2021-03-25 | $29.64M derived: sum of 3 quarters · filed 2021-03-25 | $38.16M 10-K · filed 2021-03-25 |
| 2019-09-30 | $10.03M 10-Q · filed 2020-11-10 | $20.53M derived: sum of 2 quarters · filed 2020-11-10 | $29.05M 10-Q · filed 2020-11-10 | $38.84M derived: sum of 4 quarters · filed 2020-11-10 |
| 2019-06-30 | $10.50M 10-Q · filed 2020-08-11 | $19.02M 10-Q · filed 2020-08-11 | $28.82M derived: sum of 3 quarters · filed 2020-08-11 | $38.33M derived: sum of 4 quarters · filed 2020-08-11 |
| 2019-03-31 | $8.52M 10-Q · filed 2020-05-13 | $18.31M derived: sum of 2 quarters · filed 2020-05-13 | $27.83M derived: sum of 3 quarters · filed 2020-05-13 | $36.80M derived: sum of 4 quarters · filed 2020-05-13 |
| 2018-12-31 | $9.79M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | $19.30M derived: sum of 2 quarters · filed 2020-03-25 | $28.28M derived: sum of 3 quarters · filed 2020-03-25 | $37.66M 10-K · filed 2020-03-25 |
| 2018-09-30 | $9.51M 10-Q · filed 2019-11-12 | $18.49M derived: sum of 2 quarters · filed 2019-11-12 | $27.87M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $8.97M 10-Q · filed 2019-08-06 | $18.36M 10-Q · filed 2019-08-06 | ||
| 2018-03-31 | $9.38M 10-Q · filed 2019-05-09 | |||
| 2017-12-31 | $32.48M 10-K · filed 2019-03-07 |